InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-10.4%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by VEDANTA PARTNERS, LLC. Director active across 1 company, notably Reviva Pharmaceuticals Holdings, INC.. Aggregated, 2 reports have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €5.7m. History available since 1 June 2021. The latest transaction was filed on 1 June 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
931,000 shares@ US$3.758.77% mcap50.0% of flowCommon StockSEC:0001062993-21-005353:0
Ideal exit: 26 Feb 2022 (T+270)
931,000 shares@ US$3.7550.0% of flowCommon StockSEC:0001062993-21-005353
Ideal exit: 26 Feb 2022 (T+270)
2 of 2 declarations
